Covalon Technologies Ltd. (TSXV:COV)
Canada · Delayed Price · Currency is CAD 3.570
-0.650 (-15.40%)
Sep 30, 2026, 3:59 PM EST
Covalon Technologies Market Cap
Covalon Technologies has a market cap or net worth of CAD 116.55 million as of September 30, 2026. Its market cap has increased by 99.57% in one year.
Market Cap
116.55M
Enterprise Value
98.85M
Revenue
34.35M
Ranking
n/a
PE Ratio
26.50
Stock Price
3.57
ChartMarket Cap Chart
Since September 3, 2004, Covalon Technologies's market cap has increased from 3.06M to 116.55M, an increase of 3,705.41%. That is a compound annual growth rate of 17.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 116.55M | 144.30% |
| Dec 31, 2025 | 47.71M | -46.42% |
| Dec 31, 2024 | 89.04M | 240.51% |
| Dec 29, 2023 | 26.15M | -55.61% |
| Dec 30, 2022 | 58.91M | -14.07% |
| Dec 31, 2021 | 68.55M | 130.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apotex Health | 7.35B |
| Curaleaf Holdings | 4.07B |
| Extendicare | 2.91B |
| Green Thumb Industries | 2.39B |
| Grown Rogue International | 157.46M |
| Eastwood Bio-Medical Canada | 123.99M |
| HLS Therapeutics | 121.46M |
| TelyRx Holdings | 114.80M |